Average obligated amount per year since period start.
Portion of total contract value already obligated.
Share of total value represented by subawards.
RECOMBINANT HUMAN NT-3 PROTEIN, GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR, BRAIN-DERIVED NEUROTROPHIC FACTOR, LEUKEMIA INHIBITORY FACTOR, L-ASCORBIC ACID, JAGGED 1, CILIARY NEUROTROPHIC FACTOR, AND XAV 939.
Task order obligations
Estimated months remaining until end of performance.
Period of performance
100% of period elapsed
Awarding Agency
DODEPARTMENTAL OFFICES
Code: 1406
Funding Agency
NINATIONAL INSTITUTES OF HEALTH
Code: 7529
Loading contract activity data...
Modification ID | Description | Action Date | Obligated Amount | Action Type |
|---|---|---|---|---|
Subaward # | Subawardee | Description | Amount | Action Date |
|---|---|---|---|---|